CAFE Comparison of Atypicals in First Episode of Psychosis

Clinical trial NCT00034892 · COMPLETED

Trial details

NCT number: NCT00034892
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders Mental Health Mental Disorders

Start date: 2002-03-01
Primary completion: 2005-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.